Biotechnology and Development ApS: Financial statements 2019
CVR: 33870639
Source: annual report 2019, Danish Business Authority
01/07/2018 – 30/06/2019
Biotechnology and Development ApS (CVR 33870639) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 19,289 and a net result of DKK -8,380 compared with DKK 5,553 the year before. That is a decrease of 47.1% compared with the year before. Equity in the 2019 report amounted to DKK 11,725. The solvency ratio was 10.8%.
- Gross Profit
- DKK 19,289
- Profit/Loss
- DKK -8,380
- Equity
- DKK 11,725
- Total Assets
- DKK 108,087
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 19 t. | -8 t. | 12 t. | - |
| 2018 | - | 36 t. | 6 t. | 20 t. | 1 |
| 2017 | - | 25 t. | -3 t. | 15 t. | - |
| 2016 | - | 32 t. | 13 t. | 17 t. | - |
| 2015 | - | 14 t. | 10 t. | 4 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of November 14, 2019, HCJ Silkeborg Invest A/S has been appointed auditor of Biotechnology and Development ApS.
As of November 14, 2019, ULLITS & WINTHER STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Biotechnology and Development ApS.
About Biotechnology and Development ApS
Biotechnology and Development ApS is a Danish company of the type Anpartsselskab based in Silkeborg, founded in 2011. The company is registered under the industry Engroshandel med andre råvarer og halvfabrikata. The management consists of Karl Erik Molbech. The company is owned by KLMC Holding ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 282,184 and a net result of DKK -1,709 compared with DKK 66,166 the year before. Equity in the 2025 report amounted to DKK 105,217.